Biotech

Recent Articles

3 Biotech Stocks That Could Keep Bombing

After years of unchecked rallying in biotech stocks, a correction is finally upon us. And as bad as things have been, the mean-reversion move could go even lower. More 

MNKD Stock, Take Two: Volatility or Not, You Have to Like Afrezza

Unfortunately, a bet on MNKD stock right now isn't a bet on the potential of Afrezza. But sooner or later, these facts will be reflected in MannKind shares. More 

MNKD: Buy the Rumor, Sell the News

MannKind has much to be excited about today with Afrezza, but investors need to recognize a troubling pattern that could upend MNKD stock. More 

Ready, Aim, Bargain Hunt

Those with a good risk tolerance should use the current weakness to buy high-quality, oversold stocks. More 

VIDEO: Biotechs Fall, Momentum Stocks Break Down and More

Charles Sizemore sits down to talk biotech and momentum stocks with Fox Business' Charles Payne. More 

New Biotech Breakthrough: Buy Intermune Stock

A raft of good news has powered Intermune, and I believe the good news will continue, and Intermune stock is a buy More 

Trade of the Day: Teva Pharmaceuticals (TEVA) and Mylan (MYL)

Recent price shocks in biotech stocks is a good example of the risks investors may be exposed to as healthcare continues to become more complicated. More